A Role for Two-Stage Pharmacoeconomic Appraisal?: Is There a Role for Interim Approval of a Drug for Reimbursement Based on Modelling Studies with Subsequent Full Approval Using Phase III Data?
Year of publication: |
2003
|
---|---|
Authors: | Hill, Suzanne ; Freemantle, Nick |
Published in: |
PharmacoEconomics. - Springer Healthcare | Adis, ISSN 1170-7690. - Vol. 21.2003, 11, p. 761-767
|
Publisher: |
Springer Healthcare | Adis |
Subject: | Modelling | Pharmaceutical-industry | Reimbursement |
Extent: | application/pdf text/html |
---|---|
Type of publication: | Article |
Classification: | C - Mathematical and Quantitative Methods ; D - Microeconomics ; I - Health, Education, and Welfare ; Z - Other Special Topics ; I1 - Health ; I19 - Health. Other ; I18 - Government Policy; Regulation; Public Health ; I11 - Analysis of Health Care Markets |
Source: |
-
Health Economics in the Canadian Pharmaceutical Industry
Assiff, Lila, (1999)
-
Kanavos, Panos, (1998)
-
Price Differentiation and Transparency in the Global Pharmaceutical Marketplace
Ridley, David B., (2005)
- More ...
-
Salkeld, Glenn, (1998)
-
Transparency in Economic Evaluations
Hill, Suzanne, (2005)
-
NICE, Social Values, and Balancing Objectivity and Equity
Hill, Suzanne, (2014)
- More ...